Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institute for Pure and Applied Knowledge (IPAK) is a U.S.-based nonprofit research organization founded in 2015 that conducts scientific research and public-interest analyses focused on biomedical questions, public health, and related policy issues. The organization presents itself as an independent charity performing basic, clinical, and translational biomedical research without a profit motive. Its visible activities center on observational vaccine-related studies, diagnostic-testing evaluation efforts, educational programming, and public health policy commentary rather than development of therapeutic products. IPAK does not appear to operate a conventional biopharma pipeline, and there is no evidence that it is advancing drug candidates through clinical development. For biotech diligence purposes, it is better characterized as a nonprofit health research and advocacy entity than as a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Pure and Applied Knowledge.